4.82 USD
↘ 0.19 (3.70%)AT CLOSE (11:59 AM EDT)
Seres Therapeutics, Inc.
MCRBNASDAQ • USD
4.80
↘ 0.03 (0.52%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
4.80
↘ 0.03 (0.52%)
Market: CLOSED
Seres Therapeutics, Inc. (MCRB) trades at $4.81 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics place MCRB at a fair price relative to peers.
Technical & fundamental data as of Aug 6, 2026.
Open?$5.01
High?$5.15
Low?$4.70
Prev. Close?$5.01
Volume?80.2K
Avg. Volume?103.6K
VWAP?$4.91
Rel. Volume?0.77x
Bid / Ask
Bid?$4.12 × 100
Ask?$6.06 × 100
Spread?$1.94
Midpoint?$5.09
Valuation & Ratios
Market Cap?49.8M
Shares Out?9.7M
Float?6.9M
Float %?70.8%
P/E Ratio?N/A
P/B Ratio?1.88
EPS?-$4.72
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
Employees
66
Market Cap
49.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-06-26
Address
200 SIDNEY STREET
CAMBRIDGE, MA 02139
Phone: 617 945 9626
CAMBRIDGE, MA 02139
Phone: 617 945 9626
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?18
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?-13.81Distress
Confidence?53%Low
Short InterestLow
Short % of Float?4.42%Low
Short Interest?303.4K
Days to Cover?2.0
Free Float6.9M
Avg Daily Volume151.7K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.65Adequate
Quick Ratio?1.65Adequate
Cash Ratio?1.54Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.88CHEAP▾
Peers100
S&P77
P/S?43.42HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-0.2CHEAP▾
S&P97
EV/Sales?17.41HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-177.0%WEAK▾
S&P3
ROA?-39.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-42371000
Enterprise Value?$20.0M
Fundamentals ratios updated end of day